Reverse Signaling via CD30 Ligand

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3635-3639

  Wiley, Steven R ^a,b   Goodwin, Raymond G ^a   Smith, Craig A ^a  

^a AMGEN INC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD30 LIGAND; CROSS LINKING REAGENT; HYBRID PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TNFSF8 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; NEUTROPHIL; RESPIRATORY BURST; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; CD30 LIGAND; CROSS-LINKING REAGENTS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; RECOMBINANT FUSION PROTEINS; RESPIRATORY BURST; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0030587807     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Schwab, U., H. Stein, J. Gerdes, H. Lemke, H. Kirchner, M. Schaadt, and V. Diehl. 1982. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65.
2. Piris, M., D. C. Brown, K. C. Gatter, and D. Y. Mason. 1990. CD30 expression in non-Hodgkin's lymphoma. Histopathology 17:211.
3. Froese, P., H. Lemke, J. Gerdes, B. Havsteen, R. Schwarting, H. Hansen, and H. Stein. 1987. Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines. J. Immunol. 139:2081.
4. Carde, P., L. Da Costa, L. Manil, M. Pfreundschuh, J. D. Lumbroso, J. C. Saccavini, B. Caillou, M. Ricard, F. Boudet, M. Hayat, V. Diehl, and P. Parmentier. 1990. Immunoscintigraphy of Hodgkin's disease: in vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines. Eur. J. Cancer 26:474.
5. Miettinen, M. 1992. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Arch. Pathol. Lab. Med. 116:1197.
6. Stein, H., D. Y. Mason, J. Gerdes, N. O'Connor, J. Wainscoat, G. Pallesen, K. Gatter, B. Falini, G. Delsol, H. Lemke, R. Schwarting, and K. Lennert. 1985. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848.
7. Andreesen, R., J. Osterholz, G. W. Löhr, and K. J. Bross. 1984. A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 63:1299.
8. Biswas, P., C. A. Smith, D. Goletti, E. C. Hardy, R. W. Jackson, and A. S. Fauci. 1995. Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 2:587.
9. + T cells from HIV-infected individuals. Immunity 3:251.
10. Smith, C. A., H.-J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N. G. Copeland, N. A. Jenkins, K. H. Grabstein, B. Gliniak, I. B. McAlister, W. Fanslow, M. Alderson, B. Falk, S. Gimpel, S. Gillis, W. S. Din, R. G. Goodwin, and R. J. Armitage. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349.
11. Shanebeck, K. D., C. R. Maliszewski, M. K. Kennedy, K. S. Picha, C. A. Smith, R. G. Goodwin, and K. H. Grabstein. 1995. Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 25:2147.
12. Nadali, G., F. Vinante, A. Ambrosetti, G. Todeschini, D. Veneri, R. Zanotti, V. Meneghini, M. M. Ricetti, F. Benedetti, A. Vassanelli, G. Perona, M. Chilosi, F. Menestrina, M. Fiacchini, H. Stein, and G. Pizzolo. 1994. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J. Clin. Oncol. 12:793.
13. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato, H. Stein, and G. Perona. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741.
14. Dürkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421.
15. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
16. Stüber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507.
17. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378:620.
18. Armitage, R. J., M. P. Beckmann, R. L. Idzerda, A. Alpert, and W. C. Fanslow. 1990. Regulation of interleukin 4 receptors on human T cells. Int. Immunol. 2:1039.
19. Hopp, T. P., K. S. Prickett, V. L. Price, R. T. Liggy, C. J. March, D. P. Cerretti, D. L. Urdal, and P. J. Conlon. 1988. A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6:1204.
20. Gruss, H.-J., N. Boiani, D. E. Williams, R. J. Armitage, C. A. Smith, and R. G. Goodwin. 1994. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045.
21. Zeller, J. M., L. Rothberg, and A. L. Landay. 1989. Evaluation of human monocyte oxidative metabolism utilizing a flow cytometric assay. Clin. Exp. Immunol. 78:91.
22. Kapp, A., and G. Zeck-Kapp. 1990. Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: the role of immuno-modulating cytokines. J. Invest. Dermatol. 95:94S.
23. Connelly, P. A., C. A. Farrell, J. M. Merenda, M. J. Conklyn, and H. J. Showell. 1991. Tyrosine phosphorylation is an early signaling event common to Fc receptor crosslinking in human neutrophils and rat basophilic leukemia cells (RBL-2H3). Biochem. Biophys. Res. Commun. 177:192.
24. Warren, J. S., P. A. Ward, and K. J. Johnson. 1988. Tumor necrosis factor: a plurifunctional mediator of acute inflammation. Mod. Pathol. 1:242.
25. Cerami, A., and B. Beutler. 1988. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today 9:28.
26. Larrick, J. W., and S. C. Wright. 1990. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4:3215.
27. Tracey, K. J., S. F. Lowry, and A. Cerami. 1988. The pathophysiologic role of cachectin/TNF in septic shock and cachexia. Ann. Inst. Pasteur Immunol. 139: 311.
28. Tartaglia, L. A., T. M. Ayres, G. H. W. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845.
29. Goodwin, R. G., M. R. Alderson, C. A. Smith, R. J. Armitage, T. VandenBos, R. Jerzy, T. W. Tough, M. A. Schoenborn, T. Davis-Smith, K. Hennen, B. Falk, D. Cosman, E. Baker, G. R. Sutherland, K. H. Grabstein, T. Farrah, J. G. Giri, and M. P. Beckmann. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:447.
30. Bowman, M. R., M. A. V. Crimmins, J. Yetz-Aldape, R. Kriz, K. Kelleher, and S. Herrmann. 1994. The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152:1756.
31. + T lymphocytes. J. Immunol. 152:1523.
32. Pollok, K. E., Y.-J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T-cell antigen binds Io mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24:367.
33. Banner, D. W., A. D'Arcy, W. Janes, R. Gentz, H.-J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 73:431.
34. Engelmann, H., H. Holtmann, C. Brakebusch, Y. S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497.
35. Jabara, H. H., S. M. Fu, R. S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172: 1861.
36. + CD4 T cell clones and involved in distinct immunoregulatory functions. J. Immunol. 149:3208.
37. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.